Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Staar Shakes Up U.S. Sales Force, Separating Cataract And Refractive Teams

This article was originally published in The Gray Sheet

Executive Summary

Staar Surgical is separating its U.S. refractive and cataract product sales teams as part of a major restructuring intended to reverse the recent decline in the company's domestic revenues

You may also be interested in...



People In Brief

Cordis head: Johnson & Johnson names Seth H.Z. Fischer company group chairman and worldwide franchise chairman of stent subsidiary Cordis, effective Jan. 1. He replaces Rick Anderson, who is leaving the company. Fischer has headed J&J's North American pharmaceuticals division since 2004 and has been with J&J since 1983. J&J recently announced a corporate restructuring that puts Cordis in the newly formed Comprehensive Care group, which also includes Ortho-Clinical Diagnostics, and the diabetes and vision care units (1"The Gray Sheet" Nov. 19, 2007, p. 11)

People In Brief

Cordis head: Johnson & Johnson names Seth H.Z. Fischer company group chairman and worldwide franchise chairman of stent subsidiary Cordis, effective Jan. 1. He replaces Rick Anderson, who is leaving the company. Fischer has headed J&J's North American pharmaceuticals division since 2004 and has been with J&J since 1983. J&J recently announced a corporate restructuring that puts Cordis in the newly formed Comprehensive Care group, which also includes Ortho-Clinical Diagnostics, and the diabetes and vision care units (1"The Gray Sheet" Nov. 19, 2007, p. 11)

CMS To Cover Some Costs For Astigmatism-Correcting Intraocular Lenses

Alcon says a Jan. 22 1ruling from CMS provides just the leg up it needed to boost sales of its astigmatism-correcting intraocular lens, the AcrySof Toric

Related Content

UsernamePublicRestriction

Register

MT025136

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel